Nodality completes $15.5 million financing

Nodality has announced that it completed a financing which raised $15.5 million. The round was led by Pfizer Ventures and Laboratory Corporation of America, with additional participation from previous investors, including Kleiner Perkins Caulfield & Byers, TPG Biotechnology, and Maverick Capital. Proceeds from this financing will be used to support commercial activities associated with the company’s launch of its first test in acute myelogenous leukemia, as well as to advance ongoing and new research and development programs in other hematologic malignancies, autoimmune diseases, and solid tumors.